Emoxy Optic, eye drops 1%, 5ml

Composition

>

1 ml of eye drops contains:

Active ingredient:

methylethylpyridinol hydrochloride 10 mg;

excipients:

sodium sulfite (sodium sulfite anhydrous),

sodium benzoate,

potassium dihydrogen phosphate (potassium phosphate single-substituted),

sodium hydrophosphate dodecahydrate (sodium phosphate double-substituted 12-water),

methylcellulose,

water for injection.

Pharmacological action

Emoxi-optician is an antioxidant (a drug that prevents lipid peroxidation of cell membranes), which has angioprotective (increases vascular resistance), anti-aggregation (prevents platelet bonding) and antihypoxic (increases tissue resistance to oxygen deficiency) activity. Reduces capillary permeability and strengthens the vascular wall (angioprotector).

Reduces blood viscosity and platelet aggregation (antiplatelet agent). Inhibitor of free radical processes, has a membrane-stabilizing effect. It has retinoprotective properties, protects the retina and other eye tissues from the damaging effects of high-intensity light.

Promotes resorption of intraocular hemorrhages, reduces blood clotting, improves eye microcirculation. Stimulates reparative processes in the cornea (including in the early postoperative and post-wound period).

Pharmacokinetics

It quickly penetrates into organs and tissues, where it is deposited and metabolized. In the tissues of the eye, the concentration is higher than in the blood. 5 metabolites were found, represented by dealkylated and conjugated conversion products. Metabolites are excreted by the kidneys. 2-ethyl-6-methyl-3-hydroxypyridine phosphate is found in significant amounts in the liver.

Indications

It is used in adults for the following diseases and conditions: :

• hemorrhages in the anterior chamber of the eye (treatment);
• hemorrhages in the sclera in the elderly (treatment and prevention);
• corneal inflammation and burns (treatment and prevention);
• complications in myopia (treatment);
• corneal protection (when wearing contact lenses).

Use during pregnancy and lactation

The drug is contraindicated during pregnancy and lactation (breastfeeding).

Use in children

Contraindication: children and adolescents under 18 years of age.

Contraindications

• Hypersensitivity.
• Pregnancy.
• Lactation period(breastfeeding),
• children under 18 years of age.

Side effects

• Burning sensation,
• itching,
• short-term conjunctival hyperemia,
• rarely-local allergic reactions.

Interaction

Emoxi-optik should not be mixed with other medicinal products.

How to take, course of use and dosage

Emoxi-optician is instilled in the conjunctival sac 1-2 drops 2-3 times a day.

The course of treatment is 3-30 days.

If necessary and well tolerated, the course of treatment can be continued for up to 6 months and can be repeated 2-3 times a year.

Overdose

Overdose has not been established.

Special instructions

If it is necessary to simultaneously use other eye drops, the drug is instilled last, after complete absorption of the previous drops (at least after 10-15 minutes).

Form of production

Eye drops

Storage conditions

In a dark place, at a temperature not exceeding 25 °C

Shelf life

2 years

Active ingredient

Methylethylpyridinol

Conditions of release from pharmacies

By prescription

Dosage form

eye drops

Description

For adults as directed by your doctor

Indications

Inflammatory eye diseases, Eye burns, Hemorrhages in the anterior chamber of the eye